0
Login Wishlist Cart 0

IV / IO Access

1 filter active: Clear all

12 of 15 products

£24.00
£24.00

GO IO

Safeguard Medical

£110.00 – £141.00
Version:
£110.00
Version:

FBTK-1

MED-TAC International

£312.00
£312.00

01-0042RTR

Teleflex

£162.00

NIO+

Safeguard Medical

£117.00

NIO-I

Safeguard Medical

£117.00

NIO-P

Safeguard Medical

£16.00
£16.00

Dimatex

£57.00 – £73.00
Options:
£57.00
Options:

80-820

Safeguard Medical

£46.00

80-875

Safeguard Medical

£39.00
£39.00

80-801-R

Safeguard Medical

£107.00
£107.00

80-801

Safeguard Medical

£67.00
£67.00

80-801-D

Safeguard Medical

Vascular access delivers fluids, blood, and medications when a casualty needs them — peripheral IV catheters plus intraosseous (IO) systems for when veins have collapsed. The hardware behind circulation management and resuscitation.

IV/IO access supports the C in MARCH. Pair with hemorrhage control and monitoring to guide resuscitation.

How to Choose Vascular Access

The fastest route into the circulation in a stable casualty is a peripheral IV. But in shock, the veins that make an IV easy are the first to collapse — which is why intraosseous (IO) access has become the fallback when peripheral attempts fail. IO drives a needle into the marrow space, a non-collapsible vascular network that accepts fluids and drugs at flow rates approaching an IV.

IV vs. IO

RouteWhenCommon sites
Peripheral IVFirst choice in a casualty with accessible veinsForearm, antecubital, hand
Intraosseous (IO)When IV attempts fail or the patient is in collapseProximal humerus, proximal tibia, sternum

What access is for

Access is a means, not an end. In hemorrhagic shock, doctrine favors permissive hypotension — resuscitating to a palpable radial pulse and clear mentation rather than a normal blood pressure, so a forming clot isn't blown off by aggressive fluid. Whole blood is the preferred resuscitation fluid where available. Access also delivers TXA, an antifibrinolytic most effective when given early after major hemorrhage. Stock catheters, IO drivers, administration sets, and a means to run fluids under pressure.

Building an ALS loadout? Carry both IV and IO so loss of peripheral access doesn't stop resuscitation. Anchor the kit with the trauma-response brief.

Frequently Asked Questions

When do you use IO instead of IV?

Use intraosseous access when peripheral IV attempts fail or the casualty is in shock with collapsed veins. IO reaches the non-collapsible marrow space and delivers fluids and drugs at rates approaching an IV.

Where are intraosseous sites placed?

Common IO sites are the proximal humerus (often preferred for flow and comfort), the proximal tibia, and the sternum. Site choice depends on the device, the casualty, and provider training.

What is permissive hypotension?

It is resuscitating a bleeding casualty to a palpable radial pulse and clear mental status rather than a normal blood pressure. Over-aggressive fluid can raise pressure enough to dislodge a forming clot and worsen bleeding.

Why give TXA through IV or IO access?

TXA is an antifibrinolytic that helps stabilize clots and is most effective when given early after major hemorrhage. Vascular access is how it and other resuscitation fluids are delivered in the field.

What do I need to start IV or IO access?

A working setup includes catheters or an IO driver and needles, administration (IV) sets, fluids, securement, and often a pressure infuser to drive flow. Match the loadout to your scope and protocol.

Related collections

MED-TAC International Corp. is a clinician-founded, veteran-led tactical medicine provider. Product references to CoTCCC reflect committee recommendations and do not imply FDA approval or certification. This content is educational and is not a substitute for hands-on training or medical direction.

Evidence-Based Selection
CoTCCC Aligned
SDVOSB Certified
500+ Agencies

Why MED-TAC's Evidence-Based Approach Outperforms

Multi-brand curation means optimal performance — not vendor compromises.

Multi-Brand Curation

We select the best component from each manufacturer — not whatever a single vendor pushes.

  • Best tourniquet from Company A (98% effectiveness)
  • Superior hemostatic from Company D (clinical proven)
  • Optimized kit performance over vendor politics

Evidence-Based Selection

Components chosen based on clinical studies and field data — not marketing claims.

98%
Tourniquet Effectiveness
94%
Hemostatic Success
96%
Chest Seal Adhesion
95%
User Satisfaction

Professional Validation

Trusted by professionals across law enforcement, EMS, and corporate safety programs.

500+
Law Enforcement
250+
EMS Departments
1000+
Corporate Programs
50K+
Individuals Trained
CoTCCC Aligned
Current Guidelines
Stop the Bleed
Partner Program
SDVOSB Certified
Veteran-Owned Business
SAM Registered
Federal Contractor
Shopping cart

Your cart is empty.

Return to shop
Link copied to clipboard